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Summary
Autoimmune polyendocrinopathy-candidiasis-ectoder-
mal dystrophy (APECED) is a monogenic autosomal dis-
ease with recessive inheritance. It is characterized by
multiple autoimmune endocrinopathies, chronic muco-
cutaneous candidiasis, and ectodermal dystrophies. The
defective gene responsible for this disease was recently
isolated, and several different mutations in the novel
gene, AIRE, have been identified, by us and by others,
in patients with APECED. We have shown that the APE-
CED protein is mainly localized, both in vitro and in
vivo, to the cell nucleus, where it forms distinct speckles.
This accords with the predicted structural features of the
protein, which suggest involvement of AIRE in the reg-
ulation of gene transcription. Here, we report the results
of mutational analyses of a series of 112 patients with
APECED who were from various ethnic backgrounds.
A total of 16 different mutations, covering 91% of dis-
ease alleles, were observed; of these, 8 were novel. The
mutations are spread throughout the coding region of
AIRE, yet four evident mutational hotspots were ob-
served. In vitro expression of four different naturally
occurring nonsense and missense mutations revealed a
dramatically altered subcellular location of the protein
in cultured cells. Interestingly, the wild-type APECED
protein tethered to the Gal4 DNA-binding domain acted
as a strong transcriptional activator of reporter genes in
mammalian cells, whereas most of the analyzed mutant
polypeptides had lost this capacity.
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Introduction
Autoimmune polyendocrinopathy-candidiasis-ecto-
dermal dystrophy (APECED [MIM 240300]), also
known as autoimmune polyglandular syndrome type
I (APS I), is an autosomal recessive disorder. It is, to
date, the only organ-specific human autoimmune dis-
ease described that affects multiple organs and that is
known to be inherited in a Mendelian fashion. APE-
CED is characterized by various circulating tissue-spe-
cific autoantibodies that cause the destruction of the
target organs, mainly the various endocrine glands.
The patients also manifest chronic mucocutaneous
candidiasis and a wide spectrum of ectodermal dys-
trophies. The cardinal symptoms in APECED are hy-
poparathyroidism, primary adrenocortical failure,
and chronic mucocutaneous candidiasis (Ahonen et
al. 1990).
The defective gene in APECED disease was isolated
and characterized by use of the positional cloning
strategy, and it was named “AIRE” to denote auto-
immune regulator (The Finnish-German APECED
Consortium 1997; Nagamine et al. 1997). AIRE en-
codes a 545-amino-acid proline-rich protein with a
molecular weight of 58 kD. The amino acid sequence
of the APECED polypeptide includes a putative nu-
clear targeting signal between amino acids 113 and
133, and, recently, we and others have confirmed that,
in transiently transfected mammalian cell lines, the
APECED protein is mainly localized to the cell nu-
cleus, where it forms distinct speckles (Bjo¨rses et al.
1999; Heino et al. 1999a; Rinderle et al. 1999). Sev-
eral predicted features of the protein suggest that it
plays a role in the regulation of transcription. The
protein harbors two zinc fingers of plant homeodo-
main (PHD) type—motifs that are found in many nu-
clear proteins, including chromatin-modulating pro-
teins and transcription activators (Aasland et al.
1995). A putative DNA-binding domain, named
“SAND” (Gibson et al. 1998), as well as four nuclear
receptor–binding LXXLL motifs, an inverted LXXLL
domain, and a variant form of the latter (FXXLL),
hint that this protein functions as a transcription coac-
tivator (Heery et al. 1997). Furthermore, a highly con-
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served N-terminal 100-amino-acid domain that was
first described, in AIRE, by Gibson et al. (1998) and
that has a significant homology to the homogeneously
staining region (HSR) domain of Sp100 and Sp140
proteins is found in the amino acid sequence of the
APECED protein. This domain has been shown to
function as a dimerization domain in several Sp100-
related proteins (Seeler et al. 1998; Sternsdorf et al.
1999). The domain has also been named the “ASS
domain” (Mittaz et al. 1999). A mouse homologue of
AIRE that has recently been cloned shows conser-
vation of all the predicted functional domains (Blechs-
chmidt et al. 1999; Mittaz et al. 1999; Wang et al.
1999). The AIRE gene seems to have a quite-limited
pattern of expression, with detectable mRNA levels
seen only in the thymus, lymph nodes, and fetal liver
(Nagamine et al. 1997; Heino et al. 1999a). By means
of immunohistochemical staining, the APECED pro-
tein was detected in the nuclei of cells from multiple
immunologically relevant tissues, such as the thymus,
spleen, lymph nodes, and peripheral leukocytes
(Bjo¨rses et al. 1999; Heino et al. 1999a).
APECED is enriched in three genetically isolated
populations: the Finnish (estimated lifetime incidence
1/25,000), the Iranian Jewish (estimated lifetime in-
cidence 1/9,000), and the Sardinian (estimated life-
time incidence 1/14,500) populations (Ahonen et al.
1990; Zlotogora and Shapiro 1992; Rosatelli et al.
1998). However, sporadic cases of APECED are ob-
served worldwide. Twenty-one different mutations
have previously been described in these patients. They
include the common mutation in the Finnish popu-
lation, R257X, which was observed in 85% of the
Finnish APECED chromosomes (The Finnish-German
APECED Consortium 1997; Nagamine et al. 1997;
Bjo¨rses et al. 1998), and the common Sardinian mu-
tation, R139X, which is responsible for 92% of the
disease alleles in that population (Rosatelli et al.
1998).
Here, we report the results of an analysis of mutations
in the AIRE gene of 112 patients with APECED. In this
series, we characterized 16 different mutations, 8 of
which have not previously been reported. Four inter-
esting mutations were further analyzed, by transient ex-
pression in tissue-culture cells, to examine the effects of
the mutations on the subcellular targeting of APECED
protein. We also performed preliminary functional stud-
ies, to examine the potential of the wild-type andmutant
APECED proteins to activate transcription.
Patients and Methods
Patients
A series of 112 patients with APECED were sys-
tematically screened for mutations in the coding re-
gion of AIRE. Sixty-three of the patients were of Finn-
ish origin; 13 were Iranian Jewish; 12, Italian; 5,
British; 5, French; 5, German; 4, Dutch; 2, Swiss; 1,
Swedish; 1, Hungarian; and 1, Canadian. No consan-
guinity was documented in any of the families. The
diagnostic criterion for the patients was the unequiv-
ocal presence, documented by a physician, of at least
two of the following symptoms: hypoparathyroidism
(subnormal Ca and supranormal inorganic phosphate
concentrations in serum, with renal failure excluded),
primary adrenocortical failure (primary cortisol and/
or aldosterone deficiency), and chronic mucocutane-
ous candidiasis (Ahonen et al. 1990). Genomic DNA
was extracted from 10–20-ml blood samples, accord-
ing to standard procedures (Vandenplas et al. 1984).
All of the samples were drawn in accordance with the
Helsinki Declaration, and the study was approved by
the Helsinki University Hospital Ethics Committee.
Mutation Analysis
To detect the APECED mutations, all 14 exons of the
AIRE gene (European Molecular Biology Laboratory
Database and GenBank accession number AJ009610)
were amplified, by means of PCR performed on patient
DNA, with the use of primers located in the respective
flanking introns. These primers and PCR conditions are
described in table 1. PCR for SSCP was done according
to the same protocols, with the exception that 0.8 ml
a[32P]-dGTP per 50-ml reaction was added. The PCR-
amplified exons were analyzed on nondenaturing poly-
acrylamide gels, both at room temperature with 10%
glycerol and at 4C without glycerol (Orita et al. 1989).
Those exons that showed shifts on SSCP were amplified,
with use of biotinylated primers, for solid-phase se-
quencing (Syvanen et al. 1989), and both DNA strands
were sequenced with the use of PCR primers. The sam-
ples that showed no shifts on SSCP were amplified, by
PCR, for ABI377 automated sequencing. Purification of
the PCR product was done with the use of 0.25 ml (2.5
U) ExonucleaseI (Amersham Life Sciences) and 0.5 ml
(0.5 U) Shrimp Alkaline Phosphatase (SAP) (Amersham
Life Sciences), for 4.6 ml of the PCR reaction (Werle et
al. 1994). Sequencing was done in both directions, ac-
cording to the Big Dye Terminator Cycle Sequencing
protocol (PE Biosystems), with minor modifications. Se-
quencing Analysis software, version 3.2 (PE Biosystems),
was used to perform the initial basecalling of the se-
quencing traces. Sequence contigs were assembled with
the use of Sequencher software (GeneCodes Corpora-
tion). To improve basecalling accuracy and heterozygote
detection, a manual basecalling check was required,
since dye-terminator chemistry produces uneven but pre-
dictable peak patterns that are dependent on local se-
quence context (Zakeri et al. 1998). All of the detected
mutations were monitored against a control panel of 100
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Table 1
Primers and Conditions for PCR Amplification of Exons
EXON
PRIMER
CONDITIONSa
Forward Reverse
Position Sequence Position Sequence
1 22473–22493 5′-CGTGGTCGCGGGGGTATAACA-3′ 22811–22831 5′-TATCCCTGGCTCACAGGGCCT-3′ 62C; 1
2 23172–23190 5′-GGGACCCTCATGCCACCCC-3′ 23375–23394 5′-GGCTGAGTCCACCAGGACCC-3′ 65C; 2
3 23564–23584 5′-CTACCCCTGGAGAAAACCCCT-3′ 23904–23923 5′-GGTCTAGTACCCAGAGGAGA-3′ 58C; 2
4 24115–24134 5′-CACTGAGAGGGGAGGCCAGG-3′ 24244–24263 5′-AAGGGAGGCGCTCCCACTGG-3′ 64C; 2
5 24928–24948 5′-TATGTGCTTGGGAACAGTCTT-3′ 25150–25167 5′-CGTGGTCCTCCTTCCATC-3′ 62C; 0
6 26307–26326 5′-AGAAGTGCATCCAGGTTGGC-3′ 26603–26622 5′-GGAAGAGGGGCGTCAGCAAT-3′ 58C; 3
7 26603–26622 5′-ATTGCTGACGCCCCTCTTCC-3′ 26720–26739 5′-AGGGGCCTCTCCTGTGGTCT-3′ 61C; 1
8 27711–27730 5′-CATGGGCGTCTCTTGCCTGT-3′ 27862–27880 5′-TGGTTGCGCTGGCAGAGGT-3′ 62C; 1
9 28913–28933 5′-CATGTCTCTGACTGGTGGACA-3′ 29076–29094 5′-GTGGCCATGTGGACAGGAG-3′ 62C; 1
10 29609–29628 5′-CTGATGCTGACCCTTGGGTT-3′ 29849–29868 5′-GTAGGTCCTGGGCTCCTTGA-3′ 58C; 1
11 30361–30380 5′-CTCGGGTTCGGGTTCAGCTA-3′ 30553–30571 5′-CCCGCCGACCACGCTCACT-3′ 59C; 1
12 30970–30989 5′-CGGAGGTGGCACTCCTGCT-3′ 31213–31232 5′-GAGGGCCCCTGCGGCACT-3′ 60C; 2
13 32980–33000 5′-CTGTGGGAGTTGGGCTGACCT-3′ 33098–33117 5′-GGAGGAGCACCAGGAGGCCA-3′ 63C; 2
14 34263–34283 5′-AGGTTCTCACCGTCACTCTGT-3′ 34461–34481 5′-ACTGACAAGAGGTGGCGCTGT-3′ 64C; 0
NOTE.—Intronic primers and conditions used for PCR and sequencing. The PCR reactions were done in a total volume of 25 ml containing
50 ng genomic DNA, 2.5 ml Dynazyme DNA polymerase 10 # buffer, 0.2 mM each nucleotide, 3 pmol each primer, and 0.25 U Thermus
brochianus F501L DNA polymerase (Finnzymes). The PCR conditions were as follows: denaturation at 94C for 4 min, then 30 cycles of
denaturation at 94C for 30 s, annealing at a specific temperature listed in the Conditions column, and extension at 72C for 30 s, except for
the final cycle, for which extension was for 4 min and 30 s.
a The numbers “0”–“3” represent PCR reaction mixtures, with 0 denoting no dimethyl sulfoxide (DMSO)/glycerol; 1, 8.7% glycerol; 2, 5%
DMSO; and 3, 7.5% DMSO.
unrelated Finnish individuals and 32 CEPH parents, by
means of minisequencing protocols (Syvanen et al.
1993), in which the primers listed in table 2 were used.
Haplotype analyses for the markers JAI, D21S1912,
PFKL, and D21S171 were done as described elsewhere
(Bjo¨rses et al. 1996).
Antibodies
The raising and purification of a specific antibody
against the synthetic peptide of 17 amino acids repre-
senting amino acids 151–167 of the APECED polypep-
tide have been described elsewhere (Bjo¨rses et al. 1999).
To produce an antiserum against the N-terminal half of
the APECED polypeptide (amino acids 1–209), a DNA
construct coding for a GST-fusion polypeptide was pre-
pared in pGEX-2T plasmid (Amersham Life Sciences;
modified and donated by Dr. T. Sareneva, National Pub-
lic Health Institute, Helsinki). The expressed fusion pro-
tein was purified from the bacterial lysate, by use of a
preparative 8% SDS-PAGE (Bio-Rad). The fractions
containing the fusion protein were detected by means of
western blotting and were pooled, concentrated, and
used as an antigen for the immunization of rabbits. Two
rabbits were immunized by means of subcutaneous in-
jection with the fusion protein in Freund’s complete ad-
juvant. The primary injection of 150 mg fusion protein
was followed by three additional boosts of 100 mg after
10 d and 6 and 10 wk, respectively. The blood was
collected 1 wk after the last immunization, and the im-
munoglobulin G fraction of the antibodies was isolated
by Protein A Sepharose Column (Amersham Life Sci-
ences). The antibody titers and specificity were deter-
mined by means of immunofluorescence and western
blotting. For double stainings, a commercially available
Anti-FLAG M2 monoclonal mouse antibody binding to
FLAG fusion proteins (Eastman Kodak) was used.
Expression Constructs
The AIRE cDNA was previously isolated from a hu-
man adult thymus cDNA library (The Finnish-German
APECED Consortium 1997). This cDNA was cloned
into EcoRI sites of the mammalian expression vectors
SV-poly (Stacey and Schnieke 1990) and pcDNA3.1()
(Invitrogen). For double immunofluorescence labeling,
AIRE cDNA was tagged, at the N-terminal, with the 8-
amino-acid FLAG epitope recognized by the M2 mon-
oclonal antibody (Eastman Kodak). In vitro mutagen-
esis, performed with the Chameleon Double-Stranded,
Site-Directed Mutagenesis Kit (Stratagene), was used to
produce this construct, with the full-length AIRE cDNA
in SV-poly used as a template. Mutant clones were iden-
tified by PCR amplification and were analyzed by means
of solid-phase sequencing (Syvanen et al. 1989). Four
different AIRE constructs were produced that mimicked
naturally occurring APECED-causing mutations. These
included the Finnish and Iranian Jewishmajormutations
C889T and A374G, a mutation in the first PHD finger that
substituted tyrosine for one of the conserved cysteines
(Cys311), and a single C-nucleotide deletion at nucleotide
(nt) 1313. These mutations were introduced into the
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Table 2
Mutations and Primers Used For Minisequencing
Exon Mutation Primer Position
2 G358T 5
′-GCCATCCTGGACTTCTGGAGG-3′ 23282–23302
2 A374G 5
′-GAGGGTGCTGTTCAAGGACT-3′ 23299–23318
4 13 bp ins 628–629 5′-CCAAGAAGCCGGAGAGCAGCG-3′ 24182–24202
4 C637T 5′-CGGAGAGCAGCGCAGAGCAG-3′ 24191–24210
5 C727T 5′-CCGGGGACGTCCCGGGAGCC-3′ 25034–25053
6 C889T 5′-GTGGCCCGAAGCCTCTGGTT-3′ 26394–26413
8 T1051del 5
′-ACGGCGGGGAGCTCATCTGC-3′ 27767–27786
8 G1052A 5′-CGGCGGGGAGCTCATCTGCT-3′ 27768–27787
8 4-bp ins 1086–1087 5′-CTTCCACCTGGCCTGCCTGT-3′ 27807–27826
8 1085–1097del 5′-GGGCCTTCCACCTGGCCTGC-3′ 27803–27822
8 C1094A 5
′-ACCTGGCCTGCCTGTCCCCTC-3′ 27812–27832
10 A1284ins 5
′-TGGGGAACCCCTAGCCGGCAT-3′ 29680–29700
10 C1309del 5
′-CGACTCTTGTCTACAAGCAC-3′ 29706–29725
10 C1313del 5
′-TCTTGTCTACAAGCACCTGC-3′ 29710–29729
10 C ins 1364–1365 5′-CTCCTCGGGCCCTGCACCCCC-3′ 29767–29787
14 A1758T 5
′-GCGGCCCCCTTCCCCTCTG-3′ 34342–34361
NOTE.—Data are for screening of the control panel of 100 unrelated Finns, 32 CEPH
parents, and, for the Iranian Jewish mutation, 35 unrelated healthy Iranian Jews. The
minisequencing was done according to standard procedures (Syvanen et al. 1993).
wild-type AIRE by means of in vitro mutagenesis with
QuikChange Site-DirectedMutagenesis Kit (Stratagene),
and both the full-length AIRE in SV-poly and the N-
terminal FLAG-tagged construct were used as templates.
The mutagenesis primers are listed in table 3.
Cell Culture, Transfections, and Immunological
Detection
African green-monkey kidney cell line COS-1 (ATCC
CRL 1650), the human cervical carcinoma cell lineHeLa
(ATCC CCL 2), and the mouse fibroblast cell line
NIH3T3 (ATCC CRL 1658) were cultured and were
transfected, according to standard protocols in which
the FuGene transfection system (Boehringer-Mannheim)
was applied. Western blotting of COS-1 cells transfected
with different APECED constructs, as well as immu-
nofluorescent stainings and confocal microscopy, were
done as described elsewhere (Bjo¨rses et al. 1999).
Metabolic Labeling and Immunoprecipitation
COS-1 cells were seeded on 3-cm cell-culture dishes
(4 # 105 cells/well) and were cultured in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal
calf serum, penicillin, and streptomycin. At 48 h after
transfection with the different AIRE cDNA constructs,
COS-1 cells were starved, for 1 h, in cysteine-free Dul-
becco’s minimal essential medium (DMEM) and were
then labeled with 200 mCi [35S]-Cys for 1 h. The cell-
culture medium was then collected, and the cells were
lysed by freezing and melting three times in the presence
of protease inhibitor cocktail (Boehringer Mannheim).
To avoid nonspecific precipitants, we first incubated the
samples with the preimmune serum for 1 h and then
with 1:1 (v/v) solution of Protein A Sepharose (Amer-
sham Life Sciences) for 1 h. Immunoprecipitation was
then done, by adding to the supernatant, at 1:2,000 di-
lution, the antibody against the N-terminal half of the
APECED protein and by incubating overnight at 4C.
An equal volume of Protein A Sepharose solution was
again added, and the samples were incubated for 1 h at
4C; this was followed by four washes. After immuno-
precipitation, the polypeptides were electrophoresed on
an 11% SDS–polyacrylamide gel and were visualized by
autoradiography.
Analysis of Transcriptional Activation
Both the full-length AIRE cDNA and the APECED-
mutation constructs were subcloned into the EcoRI site
of the pM2 vector (from I. Sadowski, University of Brit-
ish Columbia, Vancouver, Canada) located both down-
stream of and in frame with the region encoding the
Gal4 DNA-binding domain (DBD) (Silver et al. 1984).
The reading frame was verified by DNA sequencing.
Two reporter constructs were used, both of which con-
tained the luciferase gene under the control of either the
thymidine kinase (tk) promoter with four upstream
Gal4-binding sites (pUAS4tk-LUC) (from T. Pearlmann,
Ludwig Cancer Research Institute, Stockholm, Sweden)
or a minimal promoter with five Gal4 responding ele-
ments in front of the adenovirus E1b TATA sequence
(pG5LUC) (Promega). COS-1 cells were plated on 12-
well plates (6.6 # 104 cells/well), and, after 24 h, they
were cotransfected with 40 ng pCMVb (Clontech), 200
ng either pUAS4tk-LUC or pG5LUC, and 220 ng of Gal4
DBD construct, by use of the FuGene transfection system
(Boehringer-Mannheim). At 18 h after transfection, the
medium was changed to DMEM containing 2% (v/v)
fetal bovine serum. Luciferase and b-galactosidase ac-
Table 3
Primers for Mutagenesis Constructs
MUTATION
PRIMER
Mutagenesis Selection (for SV-poly vector)
5′ FLAG 5′-CGCGCCAACACCATGGACTATAAGGACGACGACGACAAGGCGACGGACGCGGCGC3′ 5′-CCGCATGCGAATTCGAGCTCTCC-3′
C889T 5
′-CCGAAGCCTCTGGTTTGAGCCAAGGGAGCCC-3′ 5′-CCGCATGCGAATTCGAGCTCTCC-3′
Mutagenesis Forward Mutagenesis Reverse
A374G 5
′-TGCTGTTCAAGGACTGCAACCTGGAGCGCT-3′ 5′-TAGCGCTCCAGGTTGCAGTCCTTGAACAGCA-3′
G1052A 5
′-GACGGCGGGGAGCTCATCTGCTATGACGGCTGCCCTC-3′ 5′-GAGGGCAGCCGTCATAGCAGATGAGCTCCCCGCGCT-3′
C1313del 5
′-CACGACTCTTGTCTACAAGCACTGCCGCCTTC-3′ 5′-GAAGGCGGAGCCGGCAGTGCTTGTAGACAAGAGTCGTG-3′
NOTE.—The construct with the 5′ FLAG tag and the plasmids carrying the common Finnish mutation C889T were prepared by use of the Chameleon Double-Stranded Site-DirectedMutagenesis
Kit (Stratagene); the selection primer is located in the polylinker region of the SV-vector. The remaining mutation plasmids were prepared by use of the QuikChange Site-Directed Mutagenesis
Kit (Stratagene).
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tivities were assayed as described elsewhere (Moilanen
et al. 1999), and the light units were normalized against
the b-galactosidase activity, to take into account the dif-
ferent transfection efficiencies. The values obtained were
expressed as fold activation over that observed with
Gal4 DBD alone, averaged from six independent
experiments.
Results
Mutations in the AIRE Gene
Initially, we used SSCP to screen for mutations in the
AIRE gene in a series of 112 patients with APECED.
Among 96 families with APECED, 16 different muta-
tions were identified in the coding region of AIRE. All
DNA samples from 23 patients with only one or no
identified mutation were reanalyzed by sequencing all
14 exons from new PCR products. In a total of six pa-
tients, no mutation could be established after this effort,
and in six other patients, only one disease-causing allele
was found. Eight of the mutations represent new APE-
CED mutations. The mutations, which represent single-
nucleotide substitutions, small insertions, and deletions,
are summarized in table 4 and in figure 1. They appear
to be spread throughout the coding region of the AIRE
gene. However, four evident mutational hotspots were
observed: the first was located in exon 2, in the putative
homodimerization domain; the second, in exon 6, be-
tween the SAND domain and the first PHD finger; the
third, in exon 8, in the region coding for the first PHD
finger; and the fourth, in exon 10, between the two PHD
fingers (fig. 1).
Six of the mutations occurred in more than one family.
The common Finnish mutation, R257X, was found in
114 (89%) Finnish APECED chromosomes examined,
with 72% of Finnish patients being homozygous for
R257X. The carrier frequency of this mutation in Fin-
land was calculated to be 1/250 (The Finnish-German
APECED Consortium 1997). This mutation was also
observed in 16 disease chromosomes from non-Finnish
individuals (in one allele each from 6 German, 4 Italian,
2 Dutch, 2 Swiss, 1 British, and 1 Swedish individual),
combined with six different haplotypes in the APECED
region. One German, one Italian, and two Swiss patients
were homozygous for this mutation. A 13-bp deletion
occurring at nt 1094–1106 in exon 8 was also observed
in affected chromosomes from individuals of many dif-
ferent geoethnic origins. It was observed in 7 of 10 Brit-
ish disease alleles. Furthermore, it was found in two
Finnish, one Swedish, two Italian, twoGerman, and four
Dutch alleles. The results of haplotype analyses suggest
that this mutation has occurred independently several
times, since it was found on five different APECED
haplotypes.
We also analyzed samples from 13 Iranian Jewish pa-
tients with APECED. The whole coding region of the
AIRE gene and all of the exon-intron boundaries were
completely sequenced. The only difference from the
wild-type alleles was a single-nucleotide substitution at
G374A in exon 2, which resulted in the amino acid change
of tyrosine to a cysteine at position 85. This Y85C mu-
tation was found in homozygous form in all of the Ira-
nian Jewish patients, and it was found in heterozygous
form in 1 of 35 unrelated Iranian Jewish control indi-
viduals. The Y85C mutation was not detected either in
patients with any other ethnic background or in the Eu-
ropean control panel.
Subcellular Location of the Mutant APECED Proteins
For in vitro detection of the APECED protein, we used
both a polyclonal rabbit antibody raised against a syn-
thetic 17-amino-acid peptide corresponding to amino
acid residues 151–167 (Bjo¨rses et al. 1999) and an an-
tibody against the N-terminal half of the APECED poly-
peptide. The wild-type AIRE, as well as the four differ-
ent mutant forms in the SV-poly vector, were transiently
expressed in transfected COS-1 cells. The mutant forms
examined included the common Finnish and Iranian
Jewish mutants, a mutant with a cysteine-to-tyrosine
change in the first PHD finger (G1052A), and a mutant
lacking the second PHD finger (C1313del). The results of
western blotting of the transfected cell lysates with use
of the peptide antiserum revealed two polypeptides (fig.
2A). The molecular weight of the wild-type APECED
protein, as well as that of the polypeptide produced by
the mutant construct carrying the 1-bp substitution
G1052A, was 58 kD. However, the signal derived from
the protein with the mutation was significantly weaker
than that of the wild type. The construct carrying the
major Finnish mutation yielded a 28-kD polypeptide,
and the construct lacking the second PHD finger yielded
a 50-kD polypeptide; both values are in agreement with
the calculated molecular masses of these mutated pol-
ypeptides. Surprisingly, we did not detect, by means of
western blotting, any polypeptide produced by the plas-
mid carrying the Iranian Jewish A374G mutation. How-
ever, by immunoprecipitation assay done with the use
of the antibody against the N-terminal half of the APE-
CED protein, we were able to visualize the 58-kD poly-
peptide produced by this construct (fig. 2B). A 76-kD
polypeptide was detected in all samples including both
the nontransfected and empty vector-transfected COS-1
cells, and it was considered to be unspecific. APECED-
specific immunostaining was totally abolished by prein-
cubation of the antiserum with the synthetic APECED
peptide. No specific staining was observed with preim-
mune serum.
To gain information on the effects of the APECED
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Table 4
Summary of the APECED-Causing Mutations Characterized in the Present Study
Mutationa Consequence Haplotype Origin
No. of
Alleles
G358T Val80Leu 3-2-5 Italian 1
13-bp ins 628–629 Frameshift, truncated 219-amino-acid protein 5-1-4 German 1
A374G Tyr85Cys 4-4-5 Iranian Jewish 26
C637T Gln173rSTOP, truncated 172-amino-acid protein ND Italian 1
C727T Arg203rSTOP, truncated 202-amino-acid protein 4-10-3 Italian 5
C889rTFin major Arg257rSTOP, truncated 256-amino-acid protein 4-3-5 Finnish, Swedish 104
2-3-5 Finnish 2
3-3-5 Finnish 1
5-3-5 Finnish 4
6-3-5 Finnish 1
4-3-6 Finnish 1
3-2-5 Finnish 1
5-2-5 Finnish 1
4-4-7 Italian 2
4-5-2 German 1
4-5-3 German 2
5-3-5 British, Italian 3
4-5-5 Dutch 2
5-4-3 German, Swiss 6
T1051 deletion Frameshift, truncated 376-amino-acid protein 4-9-4 French 2
G1052A Cys311Tyr 4-4-5 Finnish 2
4-bp ins 1086–1087 Frameshift, truncated 371-amino acid protein 5-3-5 Italian 4
1085–1097del Frameshift, truncated 372-amino-acid protein 4-5-5 Dutch, German,
British
9
5-5-5 British, Finnish,
Canadian
5
5-3-5 Italian, Swedish 2
5-10-5 Italian, British 3
C1094A Pro326Gln 5-4-5 Finnish 1
A ins 1283–1284 Frameshift, truncated 422-amino-acid protein 5-4-3 Finnish 2
C1309 del Frameshift, truncated 478-amino-acid protein 5-2-5 French 2
C1313 del Frameshift, truncated 478-amino-acid protein 2-10-7 Italian 4
C ins 1364–1365 Frameshift, truncated 422-amino-acid protein 4-4-5 German 2
A1758T X546Cys, 60-amino-acid–longer protein 5-5-7 Finnish 3
a Eight of the mutations are novel. A heterozygous GrT substitution at nt 358, resulting in a ValrLeu missense
mutation at amino acid 80, was observed in an Italian patient. The common Iranian Jewish mutation, an ArG
substitution at nt 374 that leads to a TyrrCys change at amino acid 85, was detected in all of the disease chromosomes
from this population. A German patient was heterozygous for a 13-bp insertion in exon 4, between nt 628 and 629.
A homozygous deletion of a T at position 1051 was observed in one French patient. One Finnish patient was a compound
heterozygote for a GrA transition at position 1052, resulting in a substitution of the first cysteine residue of the PHD1
with a tyrosine. A homozygous CrA substitution at nt 1094 was found in a Finnish patient. A C1309 deletion was
found in a heterozygous form in an Italian patient. A German patient was homozygous for a C insertion between nt
1364–1365. The haplotypes over the APECED region were constructed from the markers JAI, D21S1912, and PFKL.
For the patient denoted as “ND,” no parental samples were available; therefore, the haplotypes remain uncertain. The
nucleotide positions for the cDNA are based on GenBank accession number Z97990.
mutations on the intracellular targeting of the protein,
we performed immunohistochemical analyses of mul-
tiple mammalian cell lines transfected with either the
wild-type or mutant forms of APECED. The subcel-
lular location was investigated by means of immu-
nofluorescence, with use of both the antibody de-
scribed previously and a commercial antibody against
FLAG tag cloned, in frame, to the 5′ end of the coding
region of expressed cDNAs. The wild-type protein
was localized mainly to the cell nucleus, where it
formed discrete speckles (fig. 3A). The mutated poly-
peptide produced by the common Iranian Jewish mu-
tation revealed a similar staining pattern (fig. 3C). The
bulk of the mutated polypeptide carrying the dis-
rupted first PHD finger was cytoplasmic, although
some nonorganized nuclear staining was also ob-
served. In the cytoplasm, the protein was visible as
small granules, but some filamentous staining was also
detected (fig. 3D). The truncated forms of APECED
protein were constantly detected in the cytoplasm.
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Figure 1 Schematic presentation of the APECED gene and protein structure, with the locations of all of the mutations characterized in
the present study indicated. The dark gray–shaded box indicates the highly conserved N-terminal HSR domain; blackened boxes, the LXXLL
nuclear receptor–binding domains; horizontally striped boxes, the putative nuclear targeting signal; the vertically striped box, the putative DNA-
binding SAND domain; hatched boxes, the PHD zinc fingers; and the light gray–shaded box, the proline-rich region. The arrow indicates a
single-nucleotide substitution; the triangle, a small deletion; and the inverted triangle, a small insertion.
The protein resulting from the most common Finnish
mutation, which lacks both PHD fingers, mainly
yielded a filamentous staining pattern (fig. 3B),
whereas the protein lacking only the second PHD fin-
ger was observed as large granules in the cytoplasm
(fig. 3E). The immunohistochemical-staining patterns
obtained with the polyclonal APECED antiserum
completely overlapped with the stainings obtained
with the monoclonal anti-FLAG antibody (data not
shown).
Transcriptional-Activation Properties of the APECED
Protein
Several predicted domains of the APECED protein,
together with its location in discrete speckles in the cell
nucleus, suggested that this protein may play a role in
the regulation of gene transcription. To test this hy-
pothesis, we used a eukaryotic transactivation assay.
cDNAs encoding for wild-type and for mutated APE-
CED proteins were fused, in frame, to the yeast tran-
scription factor Gal4 DNA-binding domain (DBD) in
the pM2 expression vector (fig. 4A) and were cotrans-
fected into COS-1 cells with luciferase reporter plasmids.
Two reporter constructs with different promoters con-
trolling luciferase transcription were used: (1) the herpes
simplex virus thymidine kinase (tk) promoter with four
Gal4 binding sites (pUAS4tk-LUC) and (2) a minimal
promoter containing adenovirus E1b promoter TATA
sequence with five upstream Gal-4 response elements
(pG5LUC). The luciferase activity obtained for each fu-
sion construct was compared with that produced by the
pM2 vector expressing the Gal4 DBD domain alone.
The results of six independent transfection experi-
ments revealed that the wild-type APECED protein stim-
ulates the E1b promoter 250-fold and the UAS4tk pro-
moter 100-fold. Surprisingly, the protein harboring the
Iranian Jewish APECED mutation also activated these
promoters 300-fold and 110-fold, respectively. Experi-
ments with the mutant construct expressing a polypep-
tide with a mutation in the first PHD finger produced
transcription levels that were 77-fold and 23-fold higher,
respectively. The Gal4 DBD fusion proteins lacking one
or both PHD fingers did not activate either of the tested
promoters (fig. 4B). Interestingly, the wild-type AIRE in
the pcDNA3.1() vector that produces APECED pro-
tein lacking the Gal4 DBD also slightly activated tran-
386 Am. J. Hum. Genet. 66:378–392, 2000
Figure 2 A,Western blot analyses of cell extracts from COS-1 cells transiently expressing the wild-type and mutated forms of the APECED
protein. The cells were transfected with the plasmids indicated in the figure. All of the polypeptides were resolved by means of 11% SDS-PAGE.
The blot was probed with the rabbit antiserum against the APECED peptide. The molecular masses of the specific polypeptides are in conformity
with their calculated values. Cells transfected with the empty SV-poly vector were used as controls.B,Metabolic labeling and immunoprecipitation
of the wild-type APECED polypeptide and the polypeptide carrying the common Iranian Jewish mutation. The COS-1 cells were transfected
with the constructs indicated in the figure. After 1 h of metabolic labeling with 200 mCi of [35S]-Cys, the cell-culture medium was collected and
the cells were lysed. The antibody against the N-terminal half of the APECED protein with Protein A Sepharose was used to immunoprecipitate
the polypeptides. The immunoprecipitated samples were electrophoresed on 11% SDS-PAGE, and the polypeptides were visualized by auto-
radiography. The molecular masses of the low-range marker (Bio-Rad) are indicated on the right side of both figures.
scription from both of the promoters (∼15-fold). In con-
trol experiments with an empty pcDNA3.1() vector,
no transcriptional activation was detected.
Discussion
Mutations in the AIRE Gene
Mutations in genes encoding transcriptional regula-
tors have been described in a number of human disor-
ders. A high proportion of these mutations lead to loss
of function of the protein, and the disease is the result
of haploinsufficiency of the gene product (Engelkamp
and van Heyningen 1996). The AIRE gene encodes a
novel putative transcription coactivator that is found to
bemutated in an autoimmune disease APECED.Twenty-
one disease-causing mutations in AIRE had previously
been identified (The Finnish-German APECED Consor-
tium 1997; Nagamine et al. 1997; Myhre et al. 1998;
Pearce et al. 1998; Rosatelli et al. 1998; Scott et al. 1998;
Wang et al. 1998; Heino et al. 1999b). This report de-
scribes a mutational analysis of an extended series of
112 affected individuals, among whom 16 different mu-
tations (small insertions, deletions, or 1-bp substitu-
tions), all occurring in the coding region of the gene,
were identified. Eight of these mutations are novel,
bringing the total number of the identified mutations
causing APECED to 29. Each mutation is predicted to
result either in a truncated form of the APECED protein
or a change in the amino acid sequence. None of the
mutations was found in homozygosity in any of the con-
trol samples. By sequencing the complete coding region
and the exon-intron boundaries of the AIRE gene, we
failed to identify any mutations in 6 of the 112 patients
analyzed. However, the clinical findings and the linkage
data, taken together, indicate that these patients do have
APECED disease. In addition, in six patients, only one
mutant allele of AIRE was found. Because our sequence
analyses did not cover the promoter region or the in-
tronic sequences, the missing mutations most probably
are located in these sequences.
Eleven of the 16 APECED mutations observed in this
study are predicted to result in a severely truncated,most
likely nonfunctional, protein. Three different single-nu-
cleotide substitutions in the N-terminal half of AIRE,
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Figure 3 Subcellular locations of the wild-type and mutated APECED polypeptides. The proteins were visualized by indirect immunoflu-
orescent analysis of COS-1 cells transiently transfected with different AIRE expression constructs. The cells were fixed, permeabilized, and
incubated with the polyclonal antibody raised against the APECED peptide. A, The wild-type APECED protein is localized mainly in the cell
nucleus, where it forms distinct speckles. B, The protein carrying the common Iranian Jewish missense mutation was mainly transported to the
nucleus, where it was observed as speckles similar to those formed by the wild-type protein. C, The bulk of the 256-amino-acid–long truncated
APECED protein mimicking the common Finnish mutant was found in the cytoplasm, where the staining pattern was mainly filamentous. In
addition, some large cytoplasmic granules were detected in a fraction of cells. No staining could be observed in the nucleus.D, A point mutation
disrupting the first PHD finger of the APECED protein was mainly located in the cytoplasm. E, In a small fraction of the cells transfected with
this mutant form, some nuclear staining could also be detected, but the mutant protein failed to form any distinct structures. F, The APECED
protein lacking the second PHD finger, as a consequence of a single-nucleotide deletion, was detected, only in the cytoplasm, as small granules.
A filamentous staining pattern was observed in very few transfected cells.
which change an amino acid into a premature STOP
codon, lead to a polypeptide without either of the pre-
dicted PHD fingers. In addition, a 13-bp insertion in
exon 4 results in an even shorter polypeptide lacking the
putative DNA-binding SAND domain (nt 687–960).
Moreover, a single nt deletion, a 4-bp insertion, and a
13-bp deletion, all occurring in the region encoding the
first PHD finger, also result in a protein without any
intact PHD fingers. Four different one-nucleotide inser-
tions or deletions occurring between the two PHD fin-
gers are predicted to eliminate the second PHD finger.
In our patient series, we observed five missense mu-
tations in the AIRE gene. These mutations are of par-
ticular interest, because theymay reveal functionally crit-
ical regions of the APECED protein. Two of them,
including the common Iranian Jewish mutation, occur
in the amino-terminal conserved region of the gene en-
coded by the first two exons, and they show significant
homology to the HSR domain of Sp100 protein (Sterns-
dorf et al. 1997; Gibson et al. 1998; Sternsdorf et al.
1999). The HSR domain found in the amino termini of
the human and mouse Sp100 and Sp140 proteins, pre-
dicted to have a function in the regulation of gene ex-
pression, has recently been shown to function as a hom-
odimerization domain and, also, to be responsible for
the targeting of these proteins to the nuclear bodies
(Sternsdorf et al. 1999). The clustering of the missense
mutations in this domain, reported elsewhere (Pearce et
al. 1998), affords further evidence for the functional
significance of the motif in APECED protein.
The first PHD domain of the APECED protein harbors
two different point mutations. The CrA transition at nt
1052 changes one of the proline residues in the PHD1
into glutamine and may have the potential to disrupt
the structure of the zinc finger. The other point mutation
changes the first conserved cysteine residue of PHD1 into
tyrosine, which most likely prevents the coordination of
the zinc atom. The binding of zinc ions has been shown
to be critical for maintainance of the native three-di-
mensional structure of similar zinc fingers (Borden et al.
1995a, 1995b). The growing number of pathological
conditions caused by mutations in PHD fingers empha-
sizes the true functional significance of this particular
motif.
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Figure 4 A, Schematic diagram of the wild-type and different mutant Gal4 DBD-APECED constructs. The dark gray–shaded boxes indicate
the GAL4 DBD domains; the light gray–shaded boxes, the HSR domains; the striped boxes, the SAND domains; and the hatched boxes, PHD
zinc fingers 1 and 2. B, Comparison of the transcription-activation function of the constructs shown in panel A. The wild-type APECED tethered
to the GAL4 DBD strongly activates the pG5LUC reporter target, and this activation level is taken as 100% transcription activation. The
mutation A374G, which is the major Iranian Jewish mutation, disrupts the HSR domain of the protein. This disruption has no major effect
on the transcription-activation level, which is 115% of the wild-type activity. The Finnish major C889T mutation, which deletes both PHD
zinc fingers, has no transactivation function. Similarly, the mutant protein carrying the C1313 deletion and, thus, lacking the second PHD zinc
finger fails to cause any transcription activation. The G1052A substitution disrupts the first PHD finger, which in turn decreases the transactivation
function of the protein to 30%.
In our patients, two evident recurrent mutations,
R257X and 1085–1097del, were together responsible
for 67% of the disease alleles. The common Finnish
mutation R257X, observed in 89% of the Finnish and
in 33% of the non-Finnish affected chromosomes an-
alyzed in this study, is also reported to be the common
north Italian mutation (Scott et al. 1998). R257X was
the second-most-common mutation among both the
American and British patients with APECED. In those
populations, the most common mutation was shown
to be the 1085–1097del, which was responsible for
56.3% and 71% of the disease alleles, respectively
(Pearce et al. 1998; Wang et al. 1998). The R257X
mutation was observed on six different haplotype
backgrounds, and the 1085–1097del was observed on
five different haplotype backgrounds. These data, to-
gether with the population of origin of the patients
with APECED, provide strong evidence for the in-
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dependent origin of these mutations occurring in the
mutation-sensitive CpG sequence.
Mutations That Alter the Subcellular Location of
APECED Protein
The correct function of any protein depends on its
proper subcellular location and its ability to maintain
its macromolecular interactions. We and others have
earlier shown that the wild-type APECED protein is
mainly located in the nucleus, where it forms distinct
speckled domains throughout the nucleoplasm, ex-
cluding the nucleoli (Bjo¨rses et al. 1999; Heino et al.
1999a; Rinderle et al. 1999). To initiate the analysis
of the molecular and cellular effects of the disease-
causing mutations in AIRE, we have analyzed the sub-
cellular distribution of selected mutated forms of the
protein, when transiently expressed in mammalian cell
lines. Two of the mutations studied—the major Finn-
ish mutation and the C1313 deletion—were shown to
produce truncated proteins of 28 kD and 47 kD, re-
spectively, and were lacking either both or the second
PHD zinc-finger domains. Despite the intact nuclear
targeting sequence, these mutated APECED proteins
were predominantly retained in the cytoplasm. We ob-
served that the protein lacking both the PHD fingers
mainly produces a cytoplasmic filamentous staining
pattern, which was also occasionally seen with the
wild-type protein. This would support the previous
suggestion that the domain responsible for the vi-
mentin or microtubule binding may be located in the
N-terminal half of the protein (Rinderle et al. 1999).
Nevertheless, the protein lacking only the second PHD
finger (C1313del) failed to reveal any filamentous cy-
toplasmic staining and was observed only as large cy-
toplasmic aggregates. This may have been the result
of an altered conformation that compromised the vi-
mentin-binding properties of the protein. The mutated
form of APECED protein, with the disrupted first
PHD finger, was also detected mainly in the cyto-
plasm, where it produced small granules. In ∼10% of
the cells transiently expressing this form of the pro-
tein, some nuclear staining was also observed, but no
distinct structures were visualized. Both a nuclear and
a cytoplasmic location for the 226- and 308-amino-
acid–long N-terminal APECED fragments were also
reported by Rinderle et al. (1999). They also found
that the shorter truncated protein was associated with
vimentin or microtubuli and that the longer one
formed aggregates in the cytoplasm.
So far, the mechanism regulating the distribution of
APECED protein between the cytoplasm and the nucleus
is not known. Our results imply that the PHD zinc finger
domains, possibly together with the nuclear targeting
signal, may play an important role in determining the
subcellular distribution of the protein and its association
with specific structures in the nucleus. Similar findings
defining the involvement of zinc-finger domains in the
cellular location of proteins have previously been re-
ported. For example, mutations in the RING-finger do-
main of the ret finger protein (rfp) result in rfp remaining
in the cytoplasm of the transfected HeLa cells, whereas
the wild-type protein is localized in the nucleus (Cao et
al. 1997). The data presented here further suggest that
the pathological consequences of the mutations disturb-
ing the PHD domains may exert their effects by altering
the correct intracellular targeting of the APECED pro-
tein. That the premature termination codons created by
the nonsense mutations subject the APECED mRNAs to
rapid degradation via the nonsense-mediated mRNA de-
cay (Hentze and Kulozik 1999) is another alternative
that cannot be tested by in vitro expression studies. To
find evidence for this mechanism, transcripts or poly-
peptides should be studied in appropriate patient sam-
ples. This approach is, however, complicated by the re-
stricted tissue expression of the AIRE gene.
Activation, by APECED Protein, of In Vitro
Transcription
Both the nuclear localization and the structural fea-
tures of the APECED protein suggest that it has a func-
tion in the regulation of transcription. We explored the
transactivation potential of this protein, by means of
cotransfection experiments with Gal4 DBD-APECED
fusion protein and the luciferase reporter genes under
either the tk promoter or the adenovirus E1b TATA se-
quence with upstream Gal4 response elements. Our re-
sults demonstrate that the APECED protein is indeed
capable of activating the transcription, since GAL4
DBD-APECED fusion protein strongly stimulated both
reporter genes, providing, for the first time, experimental
evidence for the APECED protein being a transcriptional
regulator. Moreover, the truncated proteins encoded by
the cDNAs carrying APECED mutations, which in na-
tive form were inefficiently transported into the nucleus,
showed no activity in the Gal4 DBD-based transacti-
vation assay. Interestingly, a protein with a disrupted
first PHD finger but an intact second PHD finger showed
about one-third of the wild-type activity. Since a small
proportion of the native mutant protein was found in
the nuclei of the transfected cells, it is possible that this
mutant polypeptide is not totally inactive.
The Iranian Jewish APECED Mutation
APECED is enriched in three isolated populations: the
Finnish, the Sardinian, and the Iranian Jewish. In each
of these populations, the disease is associated with one
predominant haplotype, indicating a founder effect. The
common mutations in Finland and in Sardinia have been
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described elsewhere (The Finnish-German APECED
Consortium 1997; Nagamine et al. 1997; Rosatelli et al.
1998). They are both null mutations leading to severe
truncation of the polypeptide. The coding region of the
AIRE gene of the Iranian Jewish patients was sequenced
in this work. The only alteration found in this sequence
was a single-nucleotide substitution, A374G, that ex-
changes a tyrosine residue for a cysteine in the C-ter-
minal part of the HSR domain. This substitution was
detected as homozygosity in all Iranian Jewish patients
and as heterozygosity in 1 of the 35 healthy Iranian
Jewish controls, thereby implying a high carrier fre-
quency of the major mutation in this population. It was
not detected in any of the European samples. Somewhat
surprisingly, in the transactivation assay done here, the
Iranian Jewish mutant protein stimulated both of the
promoters that were tested as effectively as did the wild-
type APECED protein. The HSR domain has been
shown to be a homodimerization domain of several
Sp100-related proteins. The dimerization of the APE-
CED protein may be essential for DNA-binding or for
binding a currently unidentified partner, and mutations
in this domain could disrupt these interactions. The tran-
sactivation assay used in this study may fail to detect
the effects of the mutations on specific mechanisms of
this kind. The defective biological activity resulting in
APECED in Iranian Jewish patients may also be the re-
sult of rapid intracellular degradation of the mutated
polypeptide. The disease-causing nature of the Y85C
substitution needs to be verified by further studies.How-
ever, the clustering of three different point mutations in
the region coding for six amino acids in the C-terminus
of the putative dimerization domain supports the hy-
pothesis that these sequence alterations would cause
APECED disease.
Implications for Genotype-Phenotype Correlations
APECED is a disease with considerable phenotypic
variation. The differences observed in the clinical com-
ponents of the Finnish patients with APECED who were
known to be homozygous for the common Finnish mu-
tation and even the differences in symptoms between
siblings with APECED indicate that the allelic variation
in the AIRE gene cannot be the major determinant of
the clinical picture of the disease. The genetic back-
ground of the individual and the environmental factors
most probably play important roles in the selection of
target organs for tissue destruction. However, distinct
differences in the phenotype can be observed between
patients from two populations showing enrichment of
APECED disease. In contrast to the Finnish patientswith
APECED, the Iranian Jewish patients rarely have chronic
mucocutaneous candidiasis, and the ectodermal dystro-
phies are much less common in patients in this group
(Zlotogora and Shapiro 1992). Furthermore, hypopar-
athyroidism often is the only organ-specific autoimmune
symptom. This seems to be in accord with our finding
that the major Iranian Jewish mutation is a missense
mutation, whereas the major Finnish mutation presum-
ably leads to a totally nonfunctional truncated protein.
The Iranian Jewish mutation did not seem to have any
effect on either the subcellular location or the transac-
tivation properties assayed in this study. Even if the bulk
of the mutant polypeptide rapidly degraded, the re-
maining fraction of the protein may contain some bio-
logical activity. Whether this is also the main cause of
the milder clinical symptoms needs to be verified. We
also recognize the possibility that there may be addi-
tional nucleotide changes in the noncoding regions of
AIRE that may influence the Iranian Jewish phenotype.
Conclusion
Results of previous studies have shown that mutations
in the AIRE gene are responsible for the development
of APECED. In this study, we have identified eight novel
mutations in the AIRE gene in patients of different eth-
nic backgrounds who have APECED. On the basis of
its structural characteristics and subcellular location, the
APECED protein is suggested to be a transcriptional
regulator. For the first time, we have provided experi-
mental evidence that APECED protein acts as a powerful
transcriptional coactivator. For most of the APECED
mutants analyzed in the present study, the intracellular
location was altered, and the stimulating effect on tran-
scription, if any, was reduced. Comparison of the func-
tional properties of the mutant APECED proteins car-
rying the Finnish and Iranian Jewish commonmutations
suggests that they may partially explain differences in
the clinical phenotype of these patients. Identification of
the target genes regulated by the APECED protein and
the molecular interactions essential for its regulatory ac-
tivity remains a major challenge and is required for def-
inition of the mechanisms that trigger the destruction of
specific tissues characteristic for APECED. The infor-
mation on the interacting partners and target genes for
the APECED protein, supported by systematic func-
tional analysis of its domains and different mutations,
will extend our understanding of the role of APECED
protein in development of a normal immune response.
Furthermore, it will broaden our knowledge of the path-
ogenesis of autoimmune diseases in general.
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